Julie Parkes, Indra Neil Guha, Paul Roderick, William Rosenberg 

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 60, Issue 1, Pages (January 2014)
Volume 61, Issue 2, Pages (August 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 65, Issue 3, Pages (September 2016)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
Volume 32, Issue 2, Pages (February 2000)
Volume 41, Issue 6, Pages (December 2004)
The impact of hepatitis E in the liver transplant setting
Volume 67, Issue 3, Pages (September 2017)
Inflammasomes in liver diseases
Volume 67, Issue 3, Pages (September 2017)
Volume 50, Issue 4, Pages (April 2009)
MELD: the holy grail of organ allocation?
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies  Gennaro D'Amico, Guadalupe Garcia-Tsao, Luigi.
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis  Wichit Srikureja,
Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Millie D. Long, Bruce E. Sands 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Immigration and viral hepatitis
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Living donor liver transplantation: is the hype over?
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Reply to: “DCD consensus and futility in liver transplantation”
Volume 44, Pages S19-S24 (January 2006)
Volume 64, Issue 5, Pages (May 2016)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.
Hepatitis C core protein – The “core” of immune deception?
Assessment of FIBROSpect II to Detect Hepatic Fibrosis in Chronic Hepatitis C Patients  Atif Zaman, MD, MPH, Hugo R. Rosen, MD, Ken Ingram, PA-C, Christopher.
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Burcin Ekser, Eric Lagasse  Journal of Hepatology 
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 44, Issue 1, Pages (January 2006)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease
Volume 62, Issue 3, Pages (March 2015)
Management of cirrhosis due to chronic hepatitis C
Volume 44, Issue 3, Pages (March 2006)
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
Economics of chronic hepatitis B and hepatitis C
Volume 41, Issue 4, Pages (October 2004)
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 50, Issue 3, Pages (March 2009)
Volume 67, Issue 3, Pages (September 2017)
Immigration and viral hepatitis
Global burden of alcoholic liver diseases
Volume 64, Issue 6, Pages (June 2016)
Immunological techniques in viral hepatitis
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Volume 51, Issue 2, Pages (August 2009)
Volume 66, Issue 3, Pages (March 2017)
Volume 62, Issue 3, Pages (March 2015)
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Volume 50, Issue 1, Pages 4-6 (January 2009)
The relationship between age and fat infiltration in liver and muscle
Power of negative thinking
MELD: the holy grail of organ allocation?
Presentation transcript:

Performance of serum marker panels for liver fibrosis in chronic hepatitis C  Julie Parkes, Indra Neil Guha, Paul Roderick, William Rosenberg  Journal of Hepatology  Volume 44, Issue 3, Pages 462-474 (March 2006) DOI: 10.1016/j.jhep.2005.10.019 Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 1 (a–d) Summative receiver operator characteristic curves of panels of serum markers diagnostic of liver fibrosis at different thresholds (95% confidence intervals). (a) Mid-range thresholds: summative statistics. Diagnostic odds ratio: 6.52 (1.69–25.23); Sensitivity: 59.8%; Specificity: 87.7%. (b) Lowest reported thresholds: summative statistics. Diagnostic odds ratio: 6.39 (1.89–21.65); Sensitivity: 94.8%; Specificity: 35.8%. (c) Highest reported thresholds: Summative statistics. Diagnostic odds ratio: 8.14 (3.61–18.38); Specificity: 95%; Sensitivity: 40.1%. (d) All thresholds for all panels of tests: Summative statistics. Diagnostic odds ratio: 9.96 (8.15–12). Specificity: 71%; Sensitivity: 80%. Test for heterogeneity P=<0.0001. Journal of Hepatology 2006 44, 462-474DOI: (10.1016/j.jhep.2005.10.019) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Correct: biopsies avoided correctly (true positive true negative). Incorrect: biopsies avoided incorrectly (false negative). Inaccurate: cannot reliably attribute result for tests as tests perform with lower sensitivities/specificities at thresholds, where PPV<90%, NPV<95%. [This figure appears in colour on the web.] Journal of Hepatology 2006 44, 462-474DOI: (10.1016/j.jhep.2005.10.019) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions